AIDS

1. DIRAJLAL-FARGO S, Yu W, Jacobson DL, Mirza A, et al
   Gut permeability is associated with lower insulin sensitivity in youth living with perinatally-acquired HIV.
   AIDS. 2024 Mar 28. doi: 10.1097/QAD.0000000000003896.
   

   >> Share

   
   
2. SABERIAN C, Lurain K, Hill LK, Marshall V, et al
   Kaposi sarcoma herpesvirus viral load in bronchoalveolar lavage as a diagnostic marker for pulmonary Kaposi sarcoma.
   AIDS. 2024 Apr 2. doi: 10.1097/QAD.0000000000003897.
   

   >> Share

   
   
3. JIANG J, Wang L, Li Q, Wang Y, et al
   HIV-1 gp120 amplifies astrocyte elevated gene-1 activity to compromise the integrity of the outer blood-retinal barrier.
   AIDS. 2024;38:779-789.
   

   >> Share

   
   
4. LI N, Zheng HY, He WQ, He XY, et al
   Treatment outcomes amongst older people with HIV infection receiving antiretroviral therapy.
   AIDS. 2024;38:803-812.
   

   >> Share

   
   
5. OURSLER KK, Briggs BC, Lozano AJ, Harris NM, et al
   Association of chronotropic incompetence with reduced cardiorespiratory fitness in older adults with HIV.
   AIDS. 2024;38:825-833.
   

   >> Share

   
   
6. GOTTERT A, Malone S, Pulerwitz J
   The encouraging early successes of a dynamic choice HIV prevention model for both women and men in East Africa.
   AIDS. 2024;38:913-915.
   

   >> Share

   
   
7. ABDEL-HAMEED EA, Overton ET
   What's up with the decline in beans? Are there simple tests to identify people with HIV at risk for chronic kidney disease?
   AIDS. 2024;38:917-919.
   

   >> Share

   
   
8. FEENEY ER, Boix V, Hsue PY
   Chronotropic incompetence in HIV infection.
   AIDS. 2024;38:921-923.
   

   >> Share

   
   
9. BARR EA
   Vespers: A nursing origin story set in the dawn of the HIV pandemic.
   AIDS. 2024;38:925-927.
   

   >> Share

   
   
10. BLOT-COSSARD A, Merad Y, Bachelard A, Lebreton C, et al
    Epidemiology and characteristics of Paget's disease of bone in a French nationwide HIV cohort.
    AIDS. 2024;38:929-931.
    

    >> Share

    
    
11. 
    Sex differences in incident atherosclerotic cardiovascular disease events among women and men with HIV: Erratum.
    AIDS. 2024;38:935.
    

    >> Share

    
    

    
    AIDS Res Hum Retroviruses

12. GHASSABI F, Hashempour A, Dehghani B, Hasanshahi Z, et al
    Frequency of Fusion Inhibitor Resistance Mutations Among Therapy-Naive HIV Patients.
    AIDS Res Hum Retroviruses. 2024 Mar 30. doi: 10.1089/AID.2023.0102.
    

    >> Share

    
    

    
    Ann Intern Med

13. LI Y, Regan M, Swartwood NA, Barham T, et al
    Disparities in Tuberculosis Incidence by Race and Ethnicity Among the U.S.-Born Population in the United States, 2011 to 2021 : An Analysis of National Disease Registry Data.
    Ann Intern Med. 2024 Apr 2. doi: 10.7326/M23-2975.
    

    >> Share

    
    

    
    Clin Infect Dis

14. CACHAY ER, Gilbert T, Qin H, Mathews WC, et al
    Clinical Predictors and Outcomes of Invasive Anal Cancer for People With Human Immunodeficiency Virus in an Inception Cohort.
    Clin Infect Dis. 2024 Apr 4:ciae124. doi: 10.1093.
    

    >> Share

    
    
15. RODRIGUEZ-MOLINO P, Tebruegge M, Noguera-Julian A, Neth O, et al
    Tuberculosis disease in immunocompromised children and adolescents: a pTBnet multi-centre case-control study.
    Clin Infect Dis. 2024 Apr 3:ciae158. doi: 10.1093.
    

    >> Share

    
    
16. PODANY AT, Cramer Y, Imperial M, Rosenkranz SL, et al
    Twice-Daily Dolutegravir Based Antiretroviral Therapy with One Month of Daily Rifapentine and Isoniazid (1HP) for TB Prevention.
    Clin Infect Dis. 2024 Apr 3:ciae183. doi: 10.1093.
    

    >> Share

    
    
17. TSCHUMI N, Lukau B, Tlali K, Motaboli L, et al
    Emergence of acquired dolutegravir resistance in treatment-experienced people with HIV in Lesotho.
    Clin Infect Dis. 2024 Apr 3:ciae185. doi: 10.1093.
    

    >> Share

    
    

    
    HIV Med

18. CALZA L, Giglia M, Colangeli V, Bon I, et al
    Improvement in insulin sensitivity after switching from an integrase inhibitor-based regimen to doravirine/tenofovir disoproxil fumarate/lamivudine in people with significant weight gain.
    HIV Med. 2024 Apr 3. doi: 10.1111/hiv.13644.
    

    >> Share

    
    

    
    Int J Cancer

19. SINGINI MG, Muchengeti M, Sitas F, Chen WC, et al
    Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status.
    Int J Cancer. 2024 Apr 5. doi: 10.1002/ijc.34919.
    

    >> Share

    
    

    
    J Acquir Immune Defic Syndr

20. BUNTING SR, Feinstein BA, Vidyasagar N, Sheth NK, et al
    Psychiatry and Family Medicine Residents' Likelihood of Prescribing HIV Pre-Exposure Prophylaxis (PrEP) to Patients with Mental Illness and HIV Vulnerability.
    J Acquir Immune Defic Syndr. 2024 Mar 25. doi: 10.1097/QAI.0000000000003423.
    

    >> Share

    
    
21. ERLY S, Menza TW, Granillo L, Navejas M, et al
    Impact of COVID-19 on People Living with HIV: Data from Five Medical Monitoring Project Sites, 2020-2022.
    J Acquir Immune Defic Syndr. 2024 Apr 2. doi: 10.1097/QAI.0000000000003403.
    

    >> Share

    
    

    
    J Clin Invest

22. EICHHOLZ K, Fukazawa Y, Peterson CW, Haeseleer F, et al
    Anti-PD-1 chimeric antigen receptor T cells efficiently target SIV-infected CD4+ T cells in germinal centers.
    J Clin Invest. 2024;134:e169309.
    

    >> Share

    
    

    
    J Immunol

23. HEARPS AC, Zhou J, Agius PA, Ha P, et al
    Adaptive NK Cells Rapidly Expand during Acute HIV Infection and Persist Despite Early Initiation of Antiretroviral Therapy.
    J Immunol. 2024 Apr 1:ji2300523. doi: 10.4049/jimmunol.2300523.
    

    >> Share

    
    
24. ANDERKO RR, DePuyt AE, Bronson R, Bullotta AC, et al
    Persistence of a Skewed Repertoire of NK Cells in People with HIV-1 on Long-Term Antiretroviral Therapy.
    J Immunol. 2024 Mar 29:ji2300672. doi: 10.4049/jimmunol.2300672.
    

    >> Share

    
    

    
    J Infect Dis

25. VAN TEIJLINGEN NH, van Smoorenburg MY, Sarrami-Forooshani R, Zijlstra-Willems EM, et al
    Prevotella timonensis bacteria associated with vaginal dysbiosis enhance HIV-1 susceptibility of vaginal CD4+ T cells.
    J Infect Dis. 2024 Apr 4:jiae166. doi: 10.1093.
    

    >> Share

    
    
26. BAR ZIV O, Cahn A, Jansen T, Istomin V, et al
    Diagnosis and Risk Factors of Prediabetes and Diabetes in People Living with HIV- Evaluation of Clinical and Microbiome Parameters.
    J Infect Dis. 2024 Apr 1:jiae167. doi: 10.1093.
    

    >> Share

    
    
27. BERENGUER J, Jarrin I, Bellon JM, Diez C, et al
    Mitochondrial Haplogroups and Weight Gain After Initiating ART in Patients with HIV.
    J Infect Dis. 2024 Apr 1:jiae168. doi: 10.1093.
    

    >> Share

    
    

    
    J Med Virol

28. JIANG X, Gao Z, Sharma PP, Kumar S, et al
    Discovery of low-molecular-weight phenylalanine derivatives as novel HIV capsid modulators with improved antiretroviral activity and metabolic stability.
    J Med Virol. 2024;96:e29594.
    

    >> Share

    
    

    
    JAMA

29. HARRIS E
    WHO Documents Rising Resistance to First-Line HIV Drug.
    JAMA. 2024 Apr 5. doi: 10.1001/jama.2024.4497.
    

    >> Share

    
    

    
    PLoS Comput Biol

30. SHAO Y, Magee AF, Vasylyeva TI, Suchard MA, et al
    Scalable gradients enable Hamiltonian Monte Carlo sampling for phylodynamic inference under episodic birth-death-sampling models.
    PLoS Comput Biol. 2024;20:e1011640.
    

    >> Share

    
    
31. CASSIDY T, Stephenson KE, Barouch DH, Perelson AS, et al
    Modeling resistance to the broadly neutralizing antibody PGT121 in people living with HIV-1.
    PLoS Comput Biol. 2024;20:e1011518.
    

    >> Share

    
    

    
    PLoS One

32. NGUMBAU N, Unger JA, Wandika B, Atieno C, et al
    Mobile solutions to Empower reproductive life planning for women living with HIV in Kenya (MWACh EMPOWER): Protocol for a cluster randomized controlled trial.
    PLoS One. 2024;19:e0300642.
    

    >> Share

    
    
33. MUGO C, Adedokun O, Alo OD, Ezeokafor N, et al
    Effects of the COVID-19 pandemic on HIV service delivery and viral suppression: Findings from the SHARP program in Northern Nigeria.
    PLoS One. 2024;19:e0300335.
    

    >> Share

    
    
34. NABUKENYA S, Kyaddondo D, Munabi IG, Waitt C, et al
    The role of community engagement in promoting research participants' understanding of pharmacogenomic research results: Perspectives of stakeholders involved in HIV/AIDS research and treatment.
    PLoS One. 2024;19:e0299081.
    

    >> Share

    
    
35. MO PKH, Xin M, Wang Z, Lau JTF, et al
    Patterns of sex behaviors and factors associated with condomless anal intercourse during the COVID-19 pandemic among men who have sex with men in Hong Kong: A cross-sectional study.
    PLoS One. 2024;19:e0300988.
    

    >> Share

    
    
36. CECCARANI C, Gaspari V, Morselli S, Djusse ME, et al
    Chlamydia trachomatis and Neisseria gonorrhoeae rectal infections: Interplay between rectal microbiome, HPV infection and Torquetenovirus.
    PLoS One. 2024;19:e0301873.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

37. BISWAS A, Choudhuri I, Arnold E, Lyumkis D, et al
    Kinetic coevolutionary models predict the temporal emergence of HIV-1 resistance mutations under drug selection pressure.
    Proc Natl Acad Sci U S A. 2024;121:e2316662121.
    

    >> Share

    
    
38. SACCHI P, Wright SE, Neoptolemou P, Lampronti GI, et al
    Crystal size, shape, and conformational changes drive both the disappearance and reappearance of ritonavir polymorphs in the mill.
    Proc Natl Acad Sci U S A. 2024;121:e2319127121.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share